Clinical Trial Update: Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency) [Phase 2]

View source ↗

Summary

Phase 2 trial of STA-1 Capsule in vascular dementia has completed. No results are reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• STA-1 Capsule

Snippet

Sponsor: Sinphar Pharmaceutical Co., Ltd | Conditions: Vascular Dementia | Phase 2 | Status: COMPLETED